| Primary |
| Ischaemic Stroke |
22.7% |
| Pulmonary Embolism |
14.1% |
| Product Used For Unknown Indication |
11.0% |
| Cerebrovascular Accident |
9.9% |
| Hypertension |
7.6% |
| Acute Myocardial Infarction |
5.0% |
| Thrombolysis |
3.9% |
| Thrombosis |
3.9% |
| Cerebral Infarction |
2.6% |
| Intracardiac Thrombus |
2.6% |
| Deep Vein Thrombosis |
2.3% |
| Portal Vein Thrombosis |
2.1% |
| Cerebral Venous Thrombosis |
1.8% |
| Kawasaki's Disease |
1.8% |
| Myocardial Infarction |
1.8% |
| Purpura Fulminans |
1.6% |
| Cerebral Artery Occlusion |
1.3% |
| Fibrinous Bronchitis |
1.3% |
| Off Label Use |
1.3% |
| Venoocclusive Disease |
1.3% |
|
| Death |
18.4% |
| Haemorrhage Intracranial |
6.9% |
| Ischaemic Stroke |
5.7% |
| Vomiting |
5.7% |
| Wound Haemorrhage |
5.7% |
| Cerebral Haemorrhage |
4.6% |
| Myocardial Infarction |
4.6% |
| Pyrexia |
4.6% |
| Subarachnoid Haemorrhage |
4.6% |
| Thrombocytopenia |
4.6% |
| Angioedema |
3.4% |
| Drug Ineffective |
3.4% |
| Exposure During Pregnancy |
3.4% |
| Haemorrhage |
3.4% |
| Hemiparesis |
3.4% |
| Multi-organ Failure |
3.4% |
| Neurological Decompensation |
3.4% |
| Pneumonia |
3.4% |
| Product Quality Issue |
3.4% |
| Pulmonary Embolism |
3.4% |
|
| Secondary |
| Pulmonary Embolism |
15.0% |
| Infection |
8.4% |
| Ischaemic Stroke |
8.4% |
| Portal Vein Thrombosis |
7.5% |
| Acute Myocardial Infarction |
5.6% |
| Off Label Use |
5.6% |
| Subclavian Vein Thrombosis |
5.6% |
| Deep Vein Thrombosis |
4.7% |
| Cerebral Venous Thrombosis |
3.7% |
| Intracardiac Thrombus |
3.7% |
| Mesenteric Vein Thrombosis |
3.7% |
| Product Used For Unknown Indication |
3.7% |
| Retinal Haemorrhage |
3.7% |
| Splenic Vein Thrombosis |
3.7% |
| Thrombosis |
3.7% |
| Venoocclusive Liver Disease |
3.7% |
| Cerebral Infarction |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Atrial Fibrillation |
1.9% |
| Cerebral Artery Occlusion |
1.9% |
|
| Tachycardia |
9.1% |
| Angioedema |
6.1% |
| Cns Ventriculitis |
6.1% |
| Haemoglobin Decreased |
6.1% |
| Haemorrhage |
6.1% |
| Hemiplegia |
6.1% |
| Multi-organ Failure |
6.1% |
| Neurological Decompensation |
6.1% |
| Renal Failure Acute |
6.1% |
| Reperfusion Injury |
6.1% |
| Urticaria |
6.1% |
| Venous Thrombosis |
6.1% |
| Blood Product Transfusion |
3.0% |
| Cerebral Artery Occlusion |
3.0% |
| Cerebral Haemorrhage |
3.0% |
| Drug Ineffective |
3.0% |
| Ecchymosis |
3.0% |
| Hypertensive Crisis |
3.0% |
| Ischaemic Stroke |
3.0% |
| Mental Status Changes |
3.0% |
|
| Concomitant |
| Cardiovascular Event Prophylaxis |
27.3% |
| Anxiety |
18.2% |
| Abnormal Behaviour |
9.1% |
| Fibrinolysis |
9.1% |
| Insomnia |
9.1% |
| Pain |
9.1% |
| Pneumonia Aspiration |
9.1% |
| Prophylaxis |
9.1% |
|
| Genital Ulceration |
33.3% |
| Renal Failure Acute |
33.3% |
| Thrombocytopenia |
33.3% |
|
